Nature Communications (Mar 2022)
Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination
Abstract
Scalability, yield and quality of recombinant AAVs are a significant issue during manufacture. Here the authors describe a self-inhibiting helper plasmid strategy that improves outcomes compared to helper-free approaches.